Windlas Biotech Ipo : India Windlas Biotech Ipo To Open On 4 Aug, Speaking on the outlook of the windlas biotech.

August 04, 2021

Windlas Biotech Ipo : India Windlas Biotech Ipo To Open On 4 Aug, Speaking on the outlook of the windlas biotech.. We neither trade nor encourage our readers to trade in the grey market. Return on net worth (ronw) = 18.19% net asset value =109.36 per share. In 2001, windlas biotech limited (after this referred to as 'the company') got incorporated in delhi. Earnings per share (eps) = rs 8.70 pe ratio = na. The ipo opens on aug 4, 2021, and closes on aug 6, 2021.

Speaking on the outlook of the windlas biotech. In 2001, windlas biotech limited (after this referred to as 'the company') got incorporated in delhi. The ipo received bids for 73,89,420 shares against 61,36,252 shares on offer, as per latest data with the nse. The company was incorporated in 2001. The fresh issue was listed as aggregating up to rs 165 crore and an offer for sale of up 5,142,067 equity shares.

The shares of windlas biotech ipo will be allotted on 11 august, 2021, the tentative date of windlas biotech ipo listing is around 17 august, 2021. In 2001, windlas biotech limited (after this referred to as 'the company') got incorporated in delhi. Windlas biotech ipo opens on august 4 and closes on august 6.; The company was incorporated in 2001. Windlas biotech ipo is an ipo of windlas biotech limited which is one of the top 5 companies in pharmaceutical formulation contract development and manufacturing organization (cdmo) segment in india. However, the head office shifted to uttarakhand in 2009 under shareholders approval. Windlas biotech ltd is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organizations (cdmo) segment in india. The issue size of windlass ipo is ₹401.54 crore.

Analysts at marwadi shares, angel broking, gepl capital and bp wealth also suggest subscribing to the issue.

The bidding will close on august 6. The issue is priced at . to . per equity share. The minimum order quantity is. Windlas biotech ltd is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organizations (cdmo) segment in india. Windlas biotech ipo opens on august 4 and closes on august 6.; The price band for the issue was listed as rs 448 to rs 460 per equity share. Windlas biotech ipo, which opens today, comprises a fresh issue of shares worth rs 165 crore and an offer for sale of shares worth rs 236.5 crore (51,42,067 equity shares) by existing selling shareholders. Analysts at marwadi shares, angel broking, gepl capital and bp wealth also suggest subscribing to the issue. What is the lot size for windlas biotech limited's ipo? The fresh issue was listed as aggregating up to rs 165 crore and an offer for sale of up 5,142,067 equity shares. Windlas biotech ipo is going to hit the market on 04 aug 2021 as per the market speculations. The initial public offer of equity shares comprising a fresh issue of up to rs.401 crore. The issue is priced at ₹448 to ₹460 per equity share.

Windlas biotech is coming up with ipo that would open for subscription on 4th august 2021. The issue is priced at ₹448 to ₹460 per equity share. The issue is priced at . to . per equity share. Earnings per share (eps) = rs 8.70 pe ratio = na. The minimum order quantity is 30 shares.

Y0wuyn6ovx8km from assets-netstorage.groww.in

Retail investors can subscribe to the ipo, the minimum lot size is 30 shares, up to a maximum of 14 lots i.e. The initial public offer of equity shares comprising a fresh issue of up to rs.401 crore. The shares of windlas biotech ipo will be allotted on 11 august, 2021, the tentative date of windlas biotech ipo listing is around 17 august, 2021. Meanwhile, the price band for the ipo stood at rs 448 to rs 460 per equity share, while the grey market premium. The ipo opens on aug 4, 2021, and closes on aug 6, 2021. The fresh issue was listed as aggregating up to rs 165 crore and an offer for sale of up 5,142,067 equity shares. The issue is priced at ₹448 to ₹460 per equity share. The bidding will close on august 6.

The windlas biotech ipo has an issue size of rs 401.54 crore.

It comprises of a fresh issue worth 165 crore and an offer for sale (ofs) of rs 236.54 crore with 5,142,067 equity shares with a face value of rs 5 per share. The minimum order quantity is 30 shares. The face value of this ipo is ₹5 per equity share. 10 key things to know before the issue opens windlas biotech is amongst the top five players in the domestic pharmaceutical formulations cdmos in terms of revenue, with focus. The fresh issue was listed as aggregating up to rs 165 crore and an offer for sale of up 5,142,067 equity shares. The minimum order quantity is. The windlas biotech ipo has an issue size of rs 401.54 crore. Earnings per share (eps) = rs 8.70 pe ratio = na. Windlas biotech ipo opens on august 4 and closes on august 6.; The company to raise ₹165 crores via fresh issue and the offer for sale will be 5,142,067 shares as per drhp, the face value of the windlas biotech share is ₹5. The company plans to raise rs 401.53 crore with the help of fresh issuance of equity. The ipo received bids for 1,93,37,310 shares against 61,36,252 shares on offer, as per data with the nse. This ipo will be open for subscriptions for three consecutive days and it will close on 6 august.

Grey market premium (gmp) today: We share the gmp information for educational purposes only, so that, you can make an informed decision. Windlas biotech ipo gmp is started at good numbers as expected. The specific use of two or more drugs for single or multiple. It comprises of a fresh issue worth 165 crore and an offer for sale (ofs) of rs 236.54 crore with 5,142,067 equity shares with a face value of rs 5 per share.

Windlas Biotech Initial Public Offering Ipo To Open On August 4 R6nationals from www.r6nationals.gg

Windlas biotech counts pfizer, sanofi india, cadila healthcare and emcure pharma among its marquee customers. The minimum order quantity is 30 shares. The company plans to raise rs 401.53 crore with the help of fresh issuance of equity. The ipo opens on aug 4, 2021, and closes on aug 6, 2021. Windlas biotech ipo to hit the market on 04 august 2021 and closes on 06 august 2021. The windlas biotech ipo has an issue size of rs 401.54 crore. 10 key things to know before the issue opens windlas biotech is amongst the top five players in the domestic pharmaceutical formulations cdmos in terms of revenue, with focus. The grey market is an unofficial platform, wherein trading starts after the announcement of ipo price band till the listing of.

Windlas biotech is coming up with ipo that would open for subscription on 4th august 2021.

Meanwhile, the price band for the ipo stood at rs 448 to rs 460 per equity share, while the grey market premium. Demat account, trading application and upi id are mandatory if you are applying for an initial public offering (ipo). Return on net worth (ronw) = 18.19% net asset value =109.36 per share. Face value = rs 5. What is the lot size for windlas biotech limited's ipo? The fresh issue was listed as aggregating up to rs 165 crore and an offer for sale of up 5,142,067 equity shares. Windlas biotech's ipo was subscribed 3.15 times on the first day, with the retail individual investors category receiving 6.12 times subscription. Windlas biotech grey market premium (gmp) is around ₹ 130 today. Windlas biotech ipo subscription to start from august 04 to august 06, 2021. The ipo to raise ₹401.54 crores via ipo. Windlas biotech ltd is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organizations (cdmo) segment in india. Speaking on the outlook of the windlas biotech. The company to raise ₹165 crores via fresh issue and the offer for sale will be 5,142,067 shares as per drhp, the face value of the windlas biotech share is ₹5.